「ma」の検索結果
175件：61～65件目を表示
-
学会发表 | 研究与开发 | 千寿制药株式会社
United States of America Inhibitory effect of a novel TRPV1 antagonist, motugivatrep, on the inflammatory response in dendritic cells Tsukasa Yagi, Mari Isomi, Atsuhiro Kanda ARVO 2026 開催日：2026年5月３日～...
http://www.senju.co.jp/chinese/rd/society/ -
千寿製薬株式会社
quot; for the treatment of Allergic Conjunctivitis（PDF） June 1, 2026 Launch of Distribution of 3in1Smart and SPM-700（PDF） April 6, 2026 Launch of “Avarept® Ophthalmic Suspension 0.3%” in Japan, A Nove...
http://www.senju.co.jp/english/ -
NewMytear CL Vitaclear Cool | OTC Products, etc. | Products | SENJU Pharmaceutical
instructions on the box and package insert and only use the eye drops if you can confirm that they may be used with soft contact lenses. CHARACTERISTICS This medicine can be used while wearing all ty...
https://www.senju.co.jp/english/products/mytearvc.html -
Mytear ALPITATTO EXα | OTC Products, etc. | Products | SENJU Pharmaceutical
This medicine is recommended for people who have continuing allergy symptoms with inflammation. Category 2 OTC medicines Mytear® ALPITATTO EXα Works on unbearable eye itching due to pollens and other ...
http://www.senju.co.jp/english/products/apex.html -
1回1滴で、充血クリアｌマイティアルミファイｌ千寿製薬
1４日目の結膜充血スコアの推移 （平均値 ± 標準誤差）（Full Analysis Set） ※Use of the ORA Calibra Redness/Hyperemia Scale was made under license from Ora,Inc 安全性 ＋ ー 安全性評価において、副作用として本品群109人中1人（0.9%）に軽度の眼圧低下が認められましたが、発現後も本品の投与は...
http://www.senju.co.jp/consumer/mytearlumify/